Found: 21
Select item for more details and to access through your institution.
Normoalbuminuria—is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4225, doi. 10.1111/dom.15752
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 2, p. 1, doi. 10.1093/gerona/glad181
- By:
- Publication type:
- Article
Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.
- Published in:
- Scientific Reports, 2015, p. 11120, doi. 10.1038/srep11120
- By:
- Publication type:
- Article
Risk of hospitalization with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real‐world data.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3054, doi. 10.1111/dom.15172
- By:
- Publication type:
- Article
Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A narrative review and proposed clinical approach.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 969, doi. 10.1111/dom.14675
- By:
- Publication type:
- Article
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01829-0
- By:
- Publication type:
- Article
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01829-0
- By:
- Publication type:
- Article
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01829-0
- By:
- Publication type:
- Article
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01521-9
- By:
- Publication type:
- Article
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01362-y
- By:
- Publication type:
- Article
From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01281-y
- By:
- Publication type:
- Article
Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.786767
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 7, p. 1, doi. 10.7326/L23-0070
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 59, doi. 10.7326/M22-2115
- By:
- Publication type:
- Article
A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2020, v. 15, n. 1, p. 1, doi. 10.1186/s13024-020-00370-y
- By:
- Publication type:
- Article
Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 4, p. 701, doi. 10.1093/ckj/sfac275
- By:
- Publication type:
- Article
Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 1, p. 63, doi. 10.3390/life12010063
- By:
- Publication type:
- Article
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
- Published in:
- Diabetes Care, 2022, v. 45, n. 10, p. 2350, doi. 10.2337/dc22-0382
- By:
- Publication type:
- Article
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
- Published in:
- 2021
- By:
- Publication type:
- journal article